Suppr超能文献

MAML1/2促进YAP/TAZ的核定位及肿瘤发生。

MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.

作者信息

Kim Jiyoung, Kwon Hyeryun, Shin You Keun, Song Gahyeon, Lee Taebok, Kim Youngeun, Jeong Wonyoung, Lee Ukjin, Zhang Xianglan, Nam Gilyeong, Jeung Hei-Cheul, Kim Wantae, Jho Eek-Hoon

机构信息

Department of Life Science, University of Seoul, 02504 Seoul, Republic of Korea.

Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 06230 Seoul, Republic of Korea.

出版信息

Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13529-13540. doi: 10.1073/pnas.1917969117. Epub 2020 Jun 1.

Abstract

The Hippo pathway plays a pivotal role in tissue homeostasis and tumor suppression. YAP and TAZ are downstream effectors of the Hippo pathway, and their activities are tightly suppressed by phosphorylation-dependent cytoplasmic retention. However, the molecular mechanisms governing YAP/TAZ nuclear localization have not been fully elucidated. Here, we report that Mastermind-like 1 and 2 (MAML1/2) are indispensable for YAP/TAZ nuclear localization and transcriptional activities. Ectopic expression or depletion of MAML1/2 induces nuclear translocation or cytoplasmic retention of YAP/TAZ, respectively. Additionally, mutation of the MAML nuclear localization signal, as well as its YAP/TAZ interacting region, both abolish nuclear localization and transcriptional activity of YAP/TAZ. Importantly, we demonstrate that the level of messenger RNA (mRNA) is regulated by microRNA-30c (miR-30c) in a cell-density-dependent manner. In vivo and clinical results suggest that MAML potentiates YAP/TAZ oncogenic function and positively correlates with YAP/TAZ activation in human cancer patients, suggesting pathological relevance in the context of cancer development. Overall, our study not only provides mechanistic insight into the regulation of YAP/TAZ subcellular localization, but it also strongly suggests that the miR30c-MAML-YAP/TAZ axis is a potential therapeutic target for developing novel cancer treatments.

摘要

河马通路在组织稳态和肿瘤抑制中起关键作用。YAP和TAZ是河马通路的下游效应物,它们的活性通过磷酸化依赖性的细胞质滞留而受到严格抑制。然而,控制YAP/TAZ核定位的分子机制尚未完全阐明。在此,我们报告主脑样蛋白1和2(MAML1/2)对于YAP/TAZ的核定位和转录活性不可或缺。异位表达或缺失MAML1/2分别诱导YAP/TAZ的核转位或细胞质滞留。此外,MAML核定位信号及其YAP/TAZ相互作用区域的突变均消除了YAP/TAZ的核定位和转录活性。重要的是,我们证明信使核糖核酸(mRNA)水平受微小核糖核酸-30c(miR-30c)以细胞密度依赖性方式调控。体内和临床结果表明,MAML增强YAP/TAZ的致癌功能,并且在人类癌症患者中与YAP/TAZ激活呈正相关,提示在癌症发生发展背景下的病理相关性。总体而言,我们的研究不仅为YAP/TAZ亚细胞定位的调控提供了机制性见解,而且还强烈表明miR30c-MAML-YAP/TAZ轴是开发新型癌症治疗方法的潜在治疗靶点。

相似文献

1
MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.MAML1/2促进YAP/TAZ的核定位及肿瘤发生。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13529-13540. doi: 10.1073/pnas.1917969117. Epub 2020 Jun 1.
4
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.SWI/SNF 复合物是 YAP 和 TAZ 的机械调节抑制剂。
Nature. 2018 Nov;563(7730):265-269. doi: 10.1038/s41586-018-0658-1. Epub 2018 Oct 31.
8

引用本文的文献

本文引用的文献

4
The Hippo Signaling Network and Its Biological Functions.Hippo 信号通路及其生物学功能。
Annu Rev Genet. 2018 Nov 23;52:65-87. doi: 10.1146/annurev-genet-120417-031621. Epub 2018 Sep 5.
7
Regulation of the Hippo pathway in cancer biology.Hippo 通路在癌症生物学中的调控。
Cell Mol Life Sci. 2018 Jul;75(13):2303-2319. doi: 10.1007/s00018-018-2804-1. Epub 2018 Mar 30.
8
The history and regulatory mechanism of the Hippo pathway.Hippo 通路的历史和调控机制。
BMB Rep. 2018 Mar;51(3):106-118. doi: 10.5483/bmbrep.2018.51.3.022.
9
The Hippo pathway in organ development, homeostasis, and regeneration.Hippo 通路在器官发育、稳态和再生中的作用。
Curr Opin Cell Biol. 2017 Dec;49:99-107. doi: 10.1016/j.ceb.2017.12.012. Epub 2018 Jan 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验